We are chasing the microscopic PC cells via PSMA scan and last December, I went through 5 radiation treatments. PSA as of June 22nd was 0.55 which indicated PC cells still present since I had an RP in Jan 2019 and subsequent treatment and ADT. I am more that a little distraught as I am a young 70 year old getting ready to marry.
thabk you
Written by
TEBozo
To view profiles and participate in discussions please or .
There are several for metastatic castration resistant cancer
- ADT plus Abiraterone plus Olaparib vs ADT plus Abiraterone, even in patients without HRR defects. Results had been favorable to the triple therapy. They finished a phase 3 clinical trial.
Many on clinical trials:
-Zen 3694
- FOR46
-CTT1403, new ligand for Lu 177
-AMG 509 immunotherapy with a BITE molecule against steap 1
-AMG 160
-HPN424 immunotherapy BITE targeting PSMA
-Car T Cell PSMA 101
-ST101
-Compalisib and Rucaparib
-ARV 110 anti androgen PROTAC ("protein disruptor")
-ODM 208 similar, but more potent than abiraterone and it may work in cancer failing abi and enza
-CAR T PSCA cell immunotherapy
-JNJ-75229414 CAR T cells
-Pt-112 antibody with platinum
-Ipatasertib for PTEN loss cancers
Pretty sure there are many others in clinical trials.
Google the compounds for information if interested.
The problem for people with advanced cancers is that most of these studies are not phase 3 studies and there are not preliminary results. Most of them are in phase 1 or 2.
it is very variable, but it is measured in years instead of months. IMHO phase II are good studies, they already know the dose of the med, there are some previous results which give you an idea about adverse events and efficacy and one gets the treatment.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.